Imagen de Portada

Pharmaceutical care practice in patients with chronic kidney disease

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Dadier Antonio Arroyo Monterroza
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Sociedad Española de Farmacia Hospitalaria 2017
Materias:	Medicina Pharmaceutical care Chronic kidney disease Pharmaceutical intervention
Acceso en línea:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Establishment of a quality indicator for pharmaceutical care
por: M. Gaspar
Publicado: (2009)

Adjusting the dosage of medication in institutionalised elderly patients with renal failure
por: B. Montañés-Pauls
Publicado: (2009)

Systematic review of the implementation and evaluation of Pharmaceutical Care in hospitalised patients (Pharmaceutical Care implementation in hospitalised patients. Systematic review)
por: M.M. Silva-Castro
Publicado: (2010)

Assessment of a pharmaceutical interventional programme in patients on medications with renal risk
por: L. Álvarez Arroyo
Publicado: (2009)

Survey of oncohematological pharmaceutical care situation in Spain
por: María José Martínez-Bautista
Publicado: (2019)

Development of a risk stratification model for pharmaceutical care in HIV patients
por: Ramón Morillo-Verdugo
Publicado: (2017)

Incidence of urinary infection among kidney-transplant recipients
por: Alan Cristyan Ramalho
Publicado: (2017)

Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology
por: María de Gracia Cantillana-Suárez
Publicado: (2018)

Plasma sTWEAK levels in chronic kidney disease stages
por: Mahmut Gok
Publicado: (2022)

Differences in hospitalization due to infectious causes between patients with hemodialysis and those with peritoneal dialysis
por: Diego Fernando Moreno-Prieto
Publicado: (2020)

Obesity and kidney disease: hidden consequences of the epidemic
por: Csaba P. Kovesdy
Publicado: (2017)

Cost minimisation analysis for darbepoetin alpha vs epoetin alpha in chronic kidney disease patients on haemodialysis
por: C. Cuesta Grueso
Publicado: (2010)

Pharmaceutical services in nursing homes in Spain
por: Elia María Fernández-Villalba
Publicado: (2020)

Public knowledge, interest, and perception of chronic kidney disease educational content in Indonesia: a cross-sectional survey
por: Zaim, Saihuddin, et al.
Publicado: (2026)

Pharmaceutical care in a school pharmacy: from consultation to resolution of drug-related problems
por: Amanda Thiemy Chiozzi Watanabe
Publicado: (2019)

Global Pharmaceutical Container Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

Chronic Kidney Disease of Unknown Etiology in Agricultural Communities
por: Miguel Almaguer
Publicado: (2014)

Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model
por: Ramón Morillo Verdugo
Publicado: (2016)

Influence of hospital admission in the pharmacotherapy complexity of HIV+ patients
por: María de las Aguas Robustillo Cortés
Publicado: (2017)

Optimisation of the prescription of medication for patients undergoing elective surgery
por: L. Girona Brumós
Publicado: (2009)

Penile necrosis secondary to uremic calciphylaxis
por: JOHN FREDY NIETO-RÍOS
Publicado: (2022)

Drug-related problems causing hospital admissions in the emergency rooms at of high complexity hospital
por: Rosa Alexandra Calvo-Salazar
Publicado: (2018)

Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure
por: C. López Cabezas
Publicado: (2006)

Global Sustainable Pharmaceutical Packaging Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman's Day
por: Giorgina B Piccoli
Publicado: (2018)

Hypokalemia results of treatment for patients in peritoneal dialysis with spironolactone
por: César A. Restrepo Valencia
Publicado: (2015)

Adherence and safety study in patients on treatment with capecitabine
por: Francisca Fernández-Ribeiro
Publicado: (2017)

بیوتکنولوژی دارویی | اصول و کاربردها
por: Qalavand, Mostafa
Publicado: (2025)

Patient safety: prescription of drugs that prolong the QT interval
por: María Jesús Hernández-Arroyo
Publicado: (2015)

Histopathology of Chronic Kidney Disease of Unknown Etiology in Salvadoran Agricultural Communities
por: Laura López-Marín
Publicado: (2014)

SENTIMENTOS E EXPECTATIVAS DE CLIENTES COM DOENÇA RENAL CRÔNICA AGUARDANDO TRANSPLANTE RENAL
por: Brunno Lessa Saldanha Xavier
Publicado: (2012)

Novel Pharmaceuticals from Kenyan Marine Cyanobacteria.
por: Dzeha, T.
Publicado: (2004)

Global Blister Packaging Machine Pharmaceutical Market 2025 To 2034
por: Sirsat, Nitin
Publicado: (2025)

Bisphenol (A) uremic toxin to take into account in the Renal disease in Hemodialysis
por: Enrique Bosch-Panadero
Publicado: (2017)

Concordance between pharmacotherapeutic complexity calculated and perceived by HIV+ patients with antiretroviral treatment
por: Mercedes Manzano-García
Publicado: (2019)

Mixture Experimentation in Pharmaceutical Formulations: A Tutorial
por: Lynne B. Hare, et al.
Publicado: (2024)

Will the Pharmaceutical Industry Need Statisticians in an AI World?
por: Chris Harbron
Publicado: (2026)

Reflection on the pharmaceutical service in nursing homes; understanding reality to cover needs
por: Juan F. Peris-Martí
Publicado: (2016)

Critical thinking in the context of clinical practice: The need to reinvent pharmacy education
por: Erika Lourenço de Freitas
Publicado: (2015)

Correction to “Mixture Experimentation in Pharmaceutical Formulations: A Tutorial”
Publicado: (2025)